Health and Healthcare
Health and Healthcare Articles
Collegium Pharma shares popped on Friday after the firm announced that it will acquire the U.S. rights to the Nucynta franchise from Assertio Therapeutics.
Published:
AbbVie released better than expected fourth-quarter financial results before the markets opened on Friday.
Published:
PPD made an exciting entrance to the market Thursday, pricing its shares at the high end of the expected price range.
Published:
Aquestive Therapeutics shares jumped on Thursday after the firm announced that it had a constructive face-to-face meeting with the FDA concerning its “first of its kind” treatment of anaphylaxis.
Published:
Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin out part of its operations. Executing this effort may create some operational uncertainty inside of...
Published:
Vivus shares jumped on Wednesday after the company announced a crucial FDA for its supplemental New Drug Application for an improved formulation of Pancreaze.
Published:
Merck reported fourth-quarter financial results before the markets opened on Wednesday that were essentially in line with expectations, yet shares retreated in early trading.
Published:
Merck is scheduled to release its fourth-quarter financial results before the markets open on Wednesday. Analysts are looking for year-over-year growth on the top and bottom lines.
Published:
Insmed is one of the few biotechs not tied to the coronavirus that is making a big move to start out the week. Essentially, the firm reported midstage study results for patients with non-cystic...
Published:
Gilead Sciences shares jumped on Monday after the company announced that it is currently working with China to develop an effective treatment for the coronavirus.
Published:
Aimmune Therapeutics shares jumped early on Monday after the FDA announced late Friday a critical approval for the firm’s peanut allergy treatment.
Published:
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
Published:
Here are some biotech companies with exposure to experimental vaccines whose shares are seeing the biggest boost from the latest coronavirus news.
Published:
A positive research call indicates that Madrigal Pharmaceuticals shares could deliver more than 100% upside to investors over the coming year or so.
Published:
OpGen shares jumped on Thursday after the company announced that it will be joining the fight against the latest coronavirus outbreak.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.